This generic clearance for FDA customer service surveys is approved consistent with the revised supporting statement of (5/25/05) under the following conditions: 1) FDA shall use the generic clearance only for customer satisfaction and web site user surveys where FDA seeks to gather information for general service improvement, not for publication or for the purpose of informing significant policy or resource allocation decisions. 2) FDA shall submit an 83-C along with an abbreviated supporting statement for individual surveys (e.g., statement of need, intended use of information, description of respondents, information collection procedures, expected response rate, justification for incentive, estimated burden). 3) OMB will respond with clearance or questions within 10 working days.
Inventory as of this Action
Requested
Previously Approved
05/31/2008
05/31/2008
05/31/2008
6,000
0
6,000
1,800
0
1,800
0
0
0
This agreeement will allow FDA to conduct customer satisfaction surveys to gain important feedback from regulated entities such as food processors, cosmetic, drug, biologic, and medical device manufacturers as well as consumers and health professionals and partner surveys of the State and local governments.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.